Clinical Trial Update: Simvastatin Plus Rifaximin in Decompensated Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating simvastatin plus rifaximin in decompensated cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Cirrhosis

Drugs mentioned

• Rifaximin (rifaximin)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Judit Pich | Conditions: Cirrhoses, Liver | Phase 2 | Status: COMPLETED